TrialMultiple sclerosis (Houndmills, Basingstoke, England)2022

Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II.

Jutta Gärtner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.